Across TCGA patient cohorts, PCMTD2 protein abundance is significantly associated with the RNA expression of many other genes, with 9,064 significant associations in total. GBM shows the largest number of these associations.

The most reproducible PCMTD2-associated genes across cancer lineages are LSM14B, SS18L1, and SRSF6. Each is linked with PCMTD2 in more than 3 cancer types. Because this analysis shows association rather than direction, both PCMTD2-to-partner and partner-to-PCMTD2 results are reported.

Each partner links to its own Q-omics profile.

protein abundance associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (PCMTD2→partner) and Y-score (partner→PCMTD2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LUAD	LSM14B →	+0.545	+0.341	.001	.002	3	4
LUAD	SS18L1 →	+0.593	+0.327	<.001	.002	3	4
BRCA	SRSF6 →	+0.631	+0.455	<.001	<.001	3	4
BRCA	UCKL1 →	+0.512	+0.352	<.001	.009	3	4
GBM	MIR3942 →	+0.860	+0.568	<.001	<.001	3	4
GBM	NUTF2P6 →	+0.486	+0.414	<.001	<.001	3	3

Each partner links to its Q-omics profile. Showing the 6 strongest of 9,064 associations by consensus.

Exploration

PCMTD2 survival (RNA) · tumor vs normal (RNA) · all PCMTD2 data types